Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants
- PMID: 22935866
- PMCID: PMC4648253
- DOI: 10.1097/INF.0b013e31827030a6
Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants
Abstract
Background: Antiretroviral drugs (ARV), specifically nucleoside analogs, are toxic to mitochondrial oxidative phosphorylation. Other metabolic pathways, such as fatty acid oxidation, organic acid metabolism and amino acid metabolism, are dependent on normal oxidative phosphorylation but remain unexamined as potential points of ARV toxicity.
Methods: We analyzed newborn screening data from New York and compared proportions of abnormal newborn metabolic screens in HIV antibody screen-positive and HIV screen-negative neonates. Subsequently, we compared acylcarnitine levels in ARV-exposed (n = 16) and ARV-unexposed (n = 14) HIV-exposed infants to assess for dysfunctional fatty and organic acid metabolism.
Results: : The rate of abnormal newborn metabolic screens in HIV screen-positive infants was higher than that in the general population (2.2% versus 1.2%; P = 0.00025), most of which were for disorders of mitochondria-related metabolism. Abnormal acylcarnitine levels occurred more frequently in ARV-exposed compared with ARV-unexposed infants (43% versus 0%; P = 0.02).
Conclusions: A higher proportion of positive metabolic screens in HIV screen-positive neonates suggests that HIV or ARV exposure is associated with dysfunctional intermediary metabolism in newborns. Abnormal acylcarnitine levels were more frequent in ARV-exposed infants, suggesting that ARV may perturb normal fatty acid oxidation in some infants. Studies designed to validate and determine the clinical significance of these findings are warranted.
Conflict of interest statement
None of the authors above have any conflicts of interest to declare.
Figures

Similar articles
-
Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.AIDS Res Hum Retroviruses. 2016 Apr;32(4):339-48. doi: 10.1089/AID.2015.0112. Epub 2016 Jan 19. AIDS Res Hum Retroviruses. 2016. PMID: 26548585 Free PMC article.
-
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.J Clin Endocrinol Metab. 2015 Sep;100(9):3260-9. doi: 10.1210/JC.2015-2198. Epub 2015 Jul 2. J Clin Endocrinol Metab. 2015. PMID: 26133363 Free PMC article.
-
Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.Pediatr Infect Dis J. 2022 Aug 1;41(8):e306-e311. doi: 10.1097/INF.0000000000003586. Epub 2022 Jul 13. Pediatr Infect Dis J. 2022. PMID: 35622436 Free PMC article.
-
A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing.Clin Biochem. 2005 Apr;38(4):296-309. doi: 10.1016/j.clinbiochem.2005.01.017. Clin Biochem. 2005. PMID: 15766731 Review.
-
Carnitine deficiency disorders in children.Ann N Y Acad Sci. 2004 Nov;1033:42-51. doi: 10.1196/annals.1320.004. Ann N Y Acad Sci. 2004. PMID: 15591002 Review.
Cited by
-
Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.AIDS Res Hum Retroviruses. 2018 Jun;34(6):536-543. doi: 10.1089/AID.2017.0314. Epub 2018 May 2. AIDS Res Hum Retroviruses. 2018. PMID: 29607651 Free PMC article.
-
Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.AIDS Res Hum Retroviruses. 2016 Apr;32(4):339-48. doi: 10.1089/AID.2015.0112. Epub 2016 Jan 19. AIDS Res Hum Retroviruses. 2016. PMID: 26548585 Free PMC article.
-
Mitochondrial changes associated with viral infectious diseases in the paediatric population.Rev Med Virol. 2021 Nov;31(6):e2232. doi: 10.1002/rmv.2232. Epub 2021 Mar 31. Rev Med Virol. 2021. PMID: 33792105 Free PMC article.
-
Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.J Clin Endocrinol Metab. 2015 Sep;100(9):3260-9. doi: 10.1210/JC.2015-2198. Epub 2015 Jul 2. J Clin Endocrinol Metab. 2015. PMID: 26133363 Free PMC article.
-
A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States.J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):319-327. doi: 10.1097/QAI.0000000000002018. J Acquir Immune Defic Syndr. 2019. PMID: 30844997 Free PMC article.
References
-
- Dagan T, Sable C, Bray J, Gerschenson M. Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? Mitochondrion. 2002 May;1(5):397–412. - PubMed
-
- Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov. 2003 Oct;2(10):812–822. - PubMed
-
- Divi RL, Leonard SL, Kuo MM, et al. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environ Mol Mutagen. 2007 Apr-May;48(3–4):201–209. - PubMed
-
- Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991 Mar 2;337(8740):508–510. - PubMed
-
- Foster C, Lyall H. HIV and mitochondrial toxicity in children. Journal of Antimicrobial Chemotherapy. 2007;61(1):8–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical